Li Z - Search Results

1

Strategies for enrichment of circulating tumor cells.

Li X, Li Y, Shao W, Li Z, Zhao R, Ye Z. Li X, et al. Among authors: li y, li z. Transl Cancer Res. 2020 Mar;9(3):2012-2025. doi: 10.21037/tcr.2020.01.17. Transl Cancer Res. 2020. PMID: 35117548 Free PMC article. Review.

2

Therapeutic Cancer Vaccines.

Ye Z, Li Z, Jin H, Qian Q. Ye Z, et al. Among authors: li z. Adv Exp Med Biol. 2016;909:139-67. doi: 10.1007/978-94-017-7555-7_3. Adv Exp Med Biol. 2016. PMID: 27240458 Review.

3

Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies.

Ye Z, Ding Y, Chen Z, Li Z, Ma S, Xu Z, Cheng L, Wang X, Zhang X, Ding N, Zhang Q, Qian Q. Ye Z, et al. Among authors: li z. Cancer Biol Ther. 2019;20(4):546-551. doi: 10.1080/15384047.2018.1538000. Epub 2018 Dec 20. Cancer Biol Ther. 2019. PMID: 30572767 Free PMC article.

4

Current Progress in CAR-T Cell Therapy for Solid Tumors.

Ma S, Li X, Wang X, Cheng L, Li Z, Zhang C, Ye Z, Qian Q. Ma S, et al. Among authors: li z, li x. Int J Biol Sci. 2019 Sep 7;15(12):2548-2560. doi: 10.7150/ijbs.34213. eCollection 2019. Int J Biol Sci. 2019. PMID: 31754328 Free PMC article. Review.

5

Immunotherapy of patient with hepatocellular carcinoma using cytotoxic T lymphocytes ex vivo activated with tumor antigen-pulsed dendritic cells.

Wang Y, Yang X, Yu Y, Xu Z, Sun Y, Liu H, Cheng J, Liu M, Sha B, Li L, Ding N, Li Z, Jin H, Qian Q. Wang Y, et al. Among authors: li z, li l. J Cancer. 2018 Jan 1;9(2):275-287. doi: 10.7150/jca.22176. eCollection 2018. J Cancer. 2018. PMID: 29344274 Free PMC article.

6

A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.

Chen H, Hu L, Luo Z, Zhang J, Zhang C, Qiu B, Dong L, Tan Y, Ding J, Tang S, Shen F, Li Z, Wang H. Chen H, et al. Among authors: li z. Mol Cancer. 2015 Nov 4;14:186. doi: 10.1186/s12943-015-0454-6. Mol Cancer. 2015. PMID: 26538215 Free PMC article.

7

αPD-1-mesoCAR-T cells partially inhibit the growth of advanced/refractory ovarian cancer in a patient along with daily apatinib.

Fang J, Ding N, Guo X, Sun Y, Zhang Z, Xie B, Li Z, Wang H, Mao W, Lin Z, Qin F, Yuan M, Chu W, Qin H, Qian Q, Xu Q. Fang J, et al. Among authors: li z. J Immunother Cancer. 2021 Feb;9(2):e001162. doi: 10.1136/jitc-2020-001162. J Immunother Cancer. 2021. PMID: 33589520 Free PMC article.

8

Evaluation of Nonviral piggyBac and lentiviral Vector in Functions of CD19chimeric Antigen Receptor T Cells and Their Antitumor Activity for CD19⁺ Tumor Cells.

Lin Z, Liu X, Liu T, Gao H, Wang S, Zhu X, Rong L, Cheng J, Cai Z, Xu F, Tan X, Lv L, Li Z, Sun Y, Qian Q. Lin Z, et al. Among authors: li z. Front Immunol. 2022 Jan 10;12:802705. doi: 10.3389/fimmu.2021.802705. eCollection 2021. Front Immunol. 2022. PMID: 35082789 Free PMC article.

9

Monitoring checkpoint inhibitors: predictive biomarkers in immunotherapy.

Zhang M, Yang J, Hua W, Li Z, Xu Z, Qian Q. Zhang M, et al. Among authors: li z. Front Med. 2019 Feb;13(1):32-44. doi: 10.1007/s11684-018-0678-0. Epub 2019 Jan 24. Front Med. 2019. PMID: 30680606 Review.

10

Low glucose promotes CD133mAb-elicited cell death via inhibition of autophagy in hepatocarcinoma cells.

Chen H, Luo Z, Sun W, Zhang C, Sun H, Zhao N, Ding J, Wu M, Li Z, Wang H. Chen H, et al. Among authors: li z. Cancer Lett. 2013 Aug 9;336(1):204-12. doi: 10.1016/j.canlet.2013.04.031. Epub 2013 May 4. Cancer Lett. 2013. PMID: 23652197

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104,501 results

Search Page